Managing Eczema in Babies: Five Things to Know
McMaster UniversityFive key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.
Five key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.
Researchers at Cornell University have come up with a reliable, skin-tight computing system that’s easy to attach and detach, and can be used for a variety of purposes – from health monitoring to fashion.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.
Your skin is a window to your overall health, and what happens on your skin is often an indicator of what’s happening inside your body.
A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma.
ROSEMONT, Ill. (October 27, 2022) — Eczema, or atopic dermatitis, is a common skin condition affecting 1 in 10 Americans. Patients with eczema often experience itchy, dry, raw, and sensitive patches of skin, which greatly impacts their quality of life. As we wrap up Eczema Awareness Month, board-certified dermatologists provide easy steps you can take at home to ease your symptoms.
Giving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma before surgery was safe and completely cleared all viable tumor in 57% of patients in a Phase II study, researchers from The University of Texas MD Anderson Cancer Center reported in Nature.
In recognition of National Healthy Skin Month in November, board-certified dermatologists are providing their top tips for caring for your skin, hair, and nails.
Numerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system’s response against various cancers.
The latest articles that have been added to the Environmental Health channel.
The use of next-generation, single-port surgical robots leads to improved cosmetic outcomes and patient perceptions of scarring after robotic kidney, bladder, or prostate surgery, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a combination approach to overcome PARP inhibitor resistance in breast and ovarian cancers, a deeper understanding of STAT3 mutations as drivers of disease progression, insights into the “obesity paradox” in men with advanced melanoma, a prognostic model for rapidly progressing vestibular schwannoma, and a role for cellular trafficking proteins in creating a metastasis-promoting lung cancer microenvironment.
A total of 54 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2022 “Top Doctors” issue, representing 28 separate specialties.
Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.
Researchers at Binghamton University, State University of New York are working to understand the molecular composition of tattoo inks to provide knowledge to artists and consumers.
The American Dermatological Association affirms the pressing need to address the defects that exist in the current medical infrastructure which prevent equal access, and consequently equitable medical outcomes, for all patients with dermatologic disorders. Issues limiting access to dermatology care are highlighted here and should urgently be addressed.
Thanks to the internet, we have the world at our fingertips, and with just a few clicks, we can easily enter our medical symptoms into websites and apps to self-diagnose illnesses. However, a new article published in the Journal of the American Academy of Dermatology reveals that online symptom checkers are often inaccurate in identifying skin rashes.
Researchers at Huntsman Cancer Institute have solved a long-standing mystery about how a cancer-promoting protein causes drug-resistent tumors to grow. They hope the discovery leads to more effective cancer drugs. Ben Myers, PhD, explains how this new science is closing the gap in understanding brain and skin tumors and how to combat them.